Zura Bio Limited (Nasdaq: ZURA) ("Zura" or the "Company"), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with ...
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients ...
— We have everything you need: full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & ...
Zura Bio raised $144 million through an underwritten public offering. The company strengthened leadership with new board and executive appointments. Funds will accelerate clinical trials for its ...
In other recent news, Zura Bio Limited announced the pricing of its public offering, setting the price at $6.25 per share, aiming to raise $125 million before expenses. The company is offering 18.2 ...
In other recent news, Zura Bio Limited announced the pricing of its public offering, setting the price at $6.25 per share, aiming to raise $125 million before expenses. The company is offering 18.2 ...
All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results